IMMvention Therapeutix

Im Mvention Therapeutix

Biotechnology, 5 Laboratory Dr, Durham, North Carolina, 27709, United States, 1-10 Employees

immventionthera.com

  • twitter
  • LinkedIn

Who is IMMVENTION THERAPEUTIX

Stealth-mode venture-funded company. Discovering and developing oral novel small molecule inhibitors for treating neurodegenerative and cardiometabolic diseases.

Read More

map
  • 5 Laboratory Dr, Durham, North Carolina, 27709, United States Headquarters: 5 Laboratory Dr, Durham, North Carolina, 27709, United States
  • 2017 Date Founded: 2017
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from IMMVENTION THERAPEUTIX

Similar Companies to IMMvention Therapeutix

Altis Biosystems

  • 11-50 11-50
  • 5 Million to 10 Million $ 5 Million to 10 Million

Enzerna Biosciences

  • 1-10 1-10
  • 1 Million to 5 Million $ 1 Million to 5 Million

VERALOX Therapeutics

  • 1-10 1-10
  • 1 Million to 5 Million $ 1 Million to 5 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding IMMvention Therapeutix

Answer: IMMvention Therapeutix's headquarters are located at 5 Laboratory Dr, Durham, North Carolina, 27709, United States

Answer: IMMvention Therapeutix's official website is https://immventionthera.com

Answer: IMMvention Therapeutix's revenue is Under $1 Million

Answer: IMMvention Therapeutix's SIC: 8731

Answer: IMMvention Therapeutix has 1-10 employees

Answer: IMMvention Therapeutix is in Biotechnology

Answer: IMMvention Therapeutix top competitors include: Altis Biosystems , Enzerna Biosciences , VERALOX Therapeutics

Answer: IMMvention Therapeutix contact info: Phone number: Website: https://immventionthera.com

Answer: Stealth-mode venture-funded company. Discovering and developing oral novel small molecule inhibitors for treating neurodegenerative and cardiometabolic diseases.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access